GEN Highlights Dean Auclair’s AI Research in Cell & Gene Therapy Manufacturing
Genetic Engineering & Biotechnology News (GEN) published a piece on how AI and machine learning could give the cell and gene therapy (CGT) sector deeper manufacturing insight and control. The article draws on a recent paper led by Northeastern researchers and quotes CPS Dean Jared Auclair, PhD, extensively, including his points on how AI can shift manufacturing from reactive to predictive, and his caution that AI implementation requires high-quality data, digital infrastructure, and multidisciplinary expertise rather than being a “plug-and-play” fix.
The piece also features comments from co-author Rominder Singh, PhD, on Northeastern’s RegSciAI work. Grateful to GEN for shining a spotlight on this important intersection of AI, regulatory science, and advanced therapy manufacturing.
🔗 AI Could Give CGT Sector Deeper Manufacturing Insights and Greater Control
